“Unraveling the Legal Labyrinth: Can AI Revolutionize Pharma Without Copyright Catastrophes?”
The life sciences industry is rapidly embracing AI, with a recent survey from the Pistoia Alliance finding that 83% of professionals now use generative AI in their workflows. The surge is unsurprising, given AI’s potential to accelerate processes across pharma and clinical research. From streamlining resource-intensive R&D processes such as lead identification and optimization, to powering analysis of complex genetic and real-world patient datasets, AI is increasingly recognized as a powerful tool that enhances human-led work.
